Abstract
Abstract
Rapid testing is essential to fighting pandemics such as coronavirus disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Exhaled human breath contains multiple volatile molecules providing powerful potential for non-invasive diagnosis of diverse medical conditions. We investigated breath detection of SARS-CoV-2 infection using cavity-enhanced direct frequency comb spectroscopy (CE-DFCS), a state-of-the-art laser spectroscopic technique capable of a real-time massive collection of broadband molecular absorption features at ro-vibrational quantum state resolution and at parts-per-trillion volume detection sensitivity. Using a total of 170 individual breath samples (83 positive and 87 negative with SARS-CoV-2 based on reverse transcription polymerase chain reaction tests), we report excellent discrimination capability for SARS-CoV-2 infection with an area under the receiver-operating-characteristics curve of 0.849(4). Our results support the development of CE-DFCS as an alternative, rapid, non-invasive test for COVID-19 and highlight its remarkable potential for optical diagnoses of diverse biological conditions and disease states.
Subject
Pulmonary and Respiratory Medicine
Reference52 articles.
1. Coronavirus Pandemic (COVID-19);Ritchie;Our World in Data,2020
2. Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19,2020
3. Artificial intelligence–enabled rapid diagnosis of patients with COVID-19;Mei;Nat. Med.,2020
4. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening;Larremore;Sci. Adv.,2021
5. Molnupiravir and Nirmatrelvir-Ritonavir: oral COVID antiviral drugs;Saravolatz;Clin. Infect. Dis.,2022
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献